Patients across Spain are reporting difficulties accessing common acetylsalicylic acid formulations, as the drug—widely known as the active ingredient in Aspirin—has appeared on the list of medicines with significant supply shortages. According to the Spanish Agency of Medicines and Medical Devices (AEMPS), which maintains the official registry of supply problems, several presentations of this analgesic and antiplatelet medication are currently experiencing distribution issues. This development marks a notable shift in the pharmaceutical landscape, as the drug is a staple in both domestic medicine cabinets and long-term cardiovascular treatment regimens.
The AEMPS, the national authority responsible for regulating pharmaceutical supply chains, monitors shortages through its Centro de Información Online de Medicamentos (CIMA). As of the latest update, the agency categorizes these supply failures based on their impact on clinical practice. While pharmacists often manage these periods by offering therapeutic alternatives or generic versions, the inclusion of such a high-volume, essential medication on the shortage list reflects broader supply chain pressures affecting the European pharmaceutical market.
Why Is Acetylsalicylic Acid in Short Supply?
Supply shortages in the pharmaceutical sector are rarely caused by a single factor. According to the European Medicines Agency (EMA), which coordinates with national bodies like the AEMPS, current challenges typically stem from a complex mix of manufacturing delays, increased global demand for raw materials, and logistical bottlenecks. For acetylsalicylic acid, a primary concern is the stability of the active pharmaceutical ingredient (API) supply, which is often sourced from a limited number of global manufacturers.
When a specific medication faces a supply shortfall, manufacturers are legally required to report the status to the AEMPS, which then publishes the expected resolution date and the availability of therapeutic alternatives. In the case of acetylsalicylic acid, the shortage is generally classified as intermittent, meaning that while specific pharmacies may be out of stock, the national supply is not entirely exhausted. Patients are advised to consult with their local pharmacist, who can verify if alternative brands with the same dosage and therapeutic effect are available.
Impact on Patients and Clinical Practice
The impact of this shortage varies significantly depending on the patient’s medical needs. For individuals using low-dose acetylsalicylic acid as a daily antiplatelet therapy to prevent cardiovascular events, continuity is critical. Medical professionals emphasize that patients should not abruptly stop taking prescribed medication without consulting their physician. According to the Spanish Society of General and Family Physicians (SEMG), when a specific medication is unavailable, doctors can often prescribe an equivalent drug or a different formulation that provides the same clinical benefit.
Pharmacists play a key role in mitigating the impact of these shortages. Under Spanish law, pharmacists can substitute a medication for an equivalent one, provided the therapeutic effect remains unchanged and the dosage is consistent with the original prescription. If a specific product is not available, patients should ask their pharmacist about authorized alternatives. The AEMPS provides a list of these alternatives directly through the CIMA portal, which is updated in real-time as supply status changes.
How to Monitor Medication Availability
The AEMPS remains the most reliable source for information regarding the availability of medicines in Spain. Residents can access the CIMA portal to check the status of any medication by its name or active ingredient. The agency lists the “status” of each drug, which is updated as soon as the manufacturer provides new information regarding production timelines or distribution schedules.
For those currently unable to find their medication, the following steps are recommended:
- Consult your local pharmacist: They have access to real-time stock information from wholesalers and can often identify if other pharmacies in the vicinity have the product in stock.
- Check the AEMPS CIMA portal: Use the official AEMPS search tool to confirm if the shortage is local or national.
- Speak with your physician: If a medication is unavailable for an extended period, your doctor may need to adjust your prescription to a different, available drug.
- Do not stockpile: Purchasing more than is necessary exacerbates supply shortages and can lead to unnecessary waste.
The situation regarding the supply of acetylsalicylic acid remains under active monitoring by the AEMPS. As global supply chains continue to recover from recent disruptions, the agency expects to see a gradual stabilization of stocks. The next official update from the AEMPS regarding national pharmaceutical supply levels is expected as part of their routine monthly reporting cycle. Readers are encouraged to share this information with those who may rely on daily cardiovascular medications, and to reach out to their healthcare providers with specific concerns regarding their treatment plans.
Worth a look